Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • leqi0001
    Junior Member
    • Jan 2025
    • 1

    #1

    NovaSeq X plus and ATACseq data

    Hi,

    I'm debating whether I should use NovaSeq X plus for my ATACseq libraries. I've tried this previously, which gave me much much lower % of mononucleosomal fragments compared to NovaSeq 6000. I think this is expected given its stronger bias to smaller fragments. How strong an effect would you expect from this type of shifted fragment length in terms of peak calling and differential accessibility analysis?

    Thanks!
  • torpedosmirk
    Junior Member
    • Mar 2025
    • 1

    #2
    Originally posted by leqi0001 View Post
    Hi,

    I'm debating whether I should use NovaSeq X plus for my ATACseq libraries. I've tried this previously, which gave me much much lower % of mononucleosomal fragments compared to NovaSeq 6000. I think this google baseball is expected given its stronger bias to smaller fragments. How strong an effect would you expect from this type of shifted fragment length in terms of peak calling and differential accessibility analysis?

    Thanks!
    When using the NovaSeq X Plus for ATAC-seq libraries, you may encounter some issues with peak calling and differential accessibility analysis. In fact, the lower proportion of single nucleosome fragments may result in fewer peaks being detected, as many peak calling algorithms are optimized for specific nucleosome models. This may result in weak peak signals, leading to under-detection or omission of important regulatory regions. As a result, regions with differential accessibility between samples may be underestimated, which may lead to misunderstandings about gene regulation.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      10-14-2026, 09:55 AM
    • SEQadmin2
      New Genomics Technologies Take Aim at Long-Standing Limits
      by SEQadmin2


      Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

      We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
      ...
      09-28-2026, 10:25 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 10-22-2026, 11:13 AM
    0 responses
    22 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-22-2026, 10:48 AM
    0 responses
    20 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-15-2026, 10:52 AM
    0 responses
    36 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-14-2026, 05:39 AM
    0 responses
    42 views
    0 reactions
    Last Post SEQadmin2  
    Working...